CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
42
CPB Quote, Financials, Valuation and Earnings
Last price:
$35.32
Seasonality move
:
1.5%
Day range:
$35.21 - $35.60
52-week range:
$35.21 - $52.81
Dividend yield:
4.28%
P/E ratio:
20.53x
P/S ratio:
1.06x
P/B ratio:
2.71x
Volume:
1.9M
Avg. volume:
2.9M
1-year change:
-20.88%
Market cap:
$10.6B
Revenue:
$9.6B
EPS (TTM):
$1.73
Analysts' Opinion
-
Consensus RatingThe Campbell's has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 13 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $42.77, The Campbell's has an estimated upside of 20.43% from its current price of $35.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $36.00 representing 100% downside risk from its current price of $35.51.
Fair Value
-
According to the consensus of 19 analysts, The Campbell's has 20.43% upside to fair value with a price target of $42.77 per share.
CPB vs. S&P 500
-
Over the past 5 trading days, The Campbell's has underperformed the S&P 500 by -1.52% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Campbell's does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Campbell's has grown year-over-year revenues for 4 quarters straight. In the most recent quarter The Campbell's reported revenues of $2.7B.
Earnings Growth
-
The Campbell's earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter The Campbell's reported earnings per share of $0.58.
Enterprise value:
17.4B
EV / Invested capital:
--
Price / LTM sales:
1.06x
EV / EBIT:
16.83x
EV / Revenue:
1.72x
PEG ratio (5yr expected):
--
EV / Free cash flow:
22.56x
Price / Operating cash flow:
13.82x
Enterprise value / EBITDA:
11.83x
Gross Profit (TTM):
$3.1B
Return On Assets:
3.49%
Net Income Margin (TTM):
5.15%
Return On Equity:
13.49%
Return On Invested Capital:
4.85%
Operating Margin:
13.18%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $9.2B | $9.3B | $10.1B | $2.5B | $2.7B | |
| Gross Profit | $2.8B | $2.9B | $3.1B | $776M | $819M | |
| Operating Income | $1.3B | $1.2B | $1.3B | $328M | $354M | |
| EBITDA | $1.6B | $1.6B | $1.5B | $413M | $445M | |
| Diluted EPS | $2.70 | $2.56 | $1.73 | $0.68 | $0.58 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $2B | $2.1B | $2.1B | $3.2B | |
| Total Assets | $12.5B | $12B | $12B | $12.1B | $15.9B | |
| Current Liabilities | $2.8B | $2.3B | $2.7B | $2.1B | $3.4B | |
| Total Liabilities | $9.6B | $8.6B | $8.4B | $8.3B | $12B | |
| Total Equity | $2.9B | $3.4B | $3.6B | $3.9B | $3.9B | |
| Total Debt | $6B | $5B | $4.6B | $4.5B | $7.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $1.1B | $1.2B | $510M | $512M | |
| Cash From Investing | -$263M | -$438M | -$3B | -$119M | -$128M | |
| Cash From Financing | -$1.1B | -$646M | $2.5B | -$313M | -$363M | |
| Free Cash Flow | $879M | $617M | $773M | $390M | $411M | |
CPB
Sector
Market Cap
$10.6B
$255.2M
Price % of 52-Week High
67.25%
73.99%
Dividend Yield
4.28%
0%
Shareholder Yield
-0.47%
3.16%
1-Year Price Total Return
-20.88%
-10.63%
Beta (5-Year)
0.138
0.394
Dividend yield:
4.28%
Annualized payout:
$1.48
Payout ratio:
85.99%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$35.93
200-day SMA
Sell
Level
$43.54
Bollinger Bands (100)
Sell
Level
37.31 - 41.13
Chaikin Money Flow
Sell
Level
-12.5M
20-day SMA
Sell
Level
$36.95
Relative Strength Index (RSI14)
Sell
Level
35.94
ADX Line
Sell
Level
37.99
Williams %R
Buy
Level
-90.1961
50-day SMA
Sell
Level
$38.44
MACD (12, 26)
Buy
Level
2.14
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-1.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8949)
Sell
CA Score
(Annual)
Level (-0.8973)
Buy
Beneish M-Score
(Annual)
Level (-2.4944)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.3073)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Over the past 150-plus years, Campbell has evolved into a leading packaged food manufacturer in North America, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2024, snacks accounted for nearly half of its revenue, followed by soup (28%), other simple meals (17%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder’s of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao’s (a deal that closed in March 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
Stock Forecast FAQ
In the current month, CPB has received 4 Buy ratings 13 Hold ratings, and 2 Sell ratings. The CPB average analyst price target in the past 3 months is $42.77.
-
Where Will The Campbell's Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Campbell's share price will rise to $42.77 per share over the next 12 months.
-
What Do Analysts Say About The Campbell's?
Analysts are divided on their view about The Campbell's share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Campbell's is a Sell and believe this share price will drop from its current level to $36.00.
-
What Is The Campbell's's Price Target?
The price target for The Campbell's over the next 1-year time period is forecast to be $42.77 according to 19 Wall Street analysts, 4 of them rate the stock a Buy, 2 rate the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is CPB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Campbell's is a Hold. 13 of 19 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CPB?
You can purchase shares of The Campbell's via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Campbell's shares.
-
What Is The The Campbell's Share Price Today?
The Campbell's was last trading at $35.32 per share. This represents the most recent stock quote for The Campbell's. Yesterday, The Campbell's closed at $35.51 per share.
-
How To Buy The Campbell's Stock Online?
In order to purchase The Campbell's stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
